Loading asset research
-5.96%
Today
Loading 1D prices…
Company profile
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Clayton, VIC, United States
Employees
7
Fiscal year end
0630
CIK
1920092
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| BOLTBolt Biotherapeutics Inc. Common Stock | $7.6M | $7.7M | -433.74% | -$17.85 | +5.90% | Hold |
| CURXCuranex Pharmaceuticals Inc Common Stock | $7.1M | $0.00 | — | -$0.17 | +5.57% | Unrated |
| SNGXSoligenix Inc. Common Stock | $7.9M | $0.00 | — | -$2.14 | 0.00% | Unrated |
| INMInMed Pharmaceuticals Inc. Common Shares | $7.1M | $0.00 | — | -$3.12 | -1.53% | Unrated |
| IMNNImunon Inc. Common Stock | $8.2M | $0.00 | — | -$6.83 | +1.38% | Buy |